Donor gift in memory of his wife leads to innovative cancer clinical trial
When JEFF SCHOTTENSTEIN’s wife, Sara, was diagnosed with gastric cancer in 2014, he immediately jumped into action and left no stone unturned in researching potential solutions to address her rare type of cancer. Working with doctors at Stanford and mobilizing a network of pharmaceutical and industry contacts, Schottenstein — featured in this video — dedicated his efforts to uncovering solutions beyond traditional treatment methods.
As Scope reports, despite the fact that his wife wouldn’t benefit, Schottenstein made a gift in her memory that he hopes might someday provide better options for others suffering from the disease. Now, thanks in large part to his gift, an innovative dual-drug trial he and his wife envisioned became reality: A new phase II clinical trial at Stanford is focusing on two immunotherapy agents for the treatment of metastatic stomach and esophageal cancers.
See the original posting in the award-winning blog Scope.